Evidence map›Paper›PMID 42555927›Full record

ArticleJMIR AI2026

Deep Learning Estimation of Forced Expiratory Volume in One Second/Forced Vital Capacity and Obstructive Lung Disease Classification From Chest Radiographs With Subgroup Performance Analysis in a North American Cohort: Retrospective Cohort Study.

Eptehal Nashnoush, Helen D'Couto, Benjamin Fine, Leo Anthony Celi, Mohamed Abdalla

Abstract read
In one paragraph

Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eptehal NashnoushTrillium Health Centre, Mississauga, ON, Canada.ORCID https://orcid.org/0009-0000-9310-4092
Helen D'CoutoMedStar Health, Washington, DC, MD, United States.ORCID https://orcid.org/0000-0002-1389-8206
Benjamin FineTrillium Health Centre, Mississauga, ON, Canada.ORCID https://orcid.org/0009-0004-7153-2642
Leo Anthony CeliMassachusetts Institute of Technology, Cambridge, MA, United States.ORCID https://orcid.org/0000-0001-6712-6626
Mohamed AbdallaTrillium Health Centre, Mississauga, ON, Canada.ORCID https://orcid.org/0000-0002-2776-6036

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpirometry is the standard physiological test defining airflow obstruction, the key criterion for diagnosing chronic obstructive pulmonary disease. It is underused in high-income settings and often unavailable in low- and middle-income countries, causing underdetection. Deep learning analysis of chest radiographs, which are widely available where spirometry is not, may complement spirometric screening, but its use in North American cohorts and across demographic strata has not been examined.

objectiveThis study aimed to train a deep learning model to estimate the forced expiratory volume in 1 second (FEV₁)/forced vital capacity (FVC) ratio from chest radiographs and classify airflow obstruction (FEV₁/FVC <0.70), evaluate it on a held-out test set, and audit subgroup performance across age, sex, and surname-inferred ethnicity.

methodsWe conducted a retrospective cohort study of 3537 adults who underwent prebronchodilator spirometry and chest radiography within 30 days at a large hospital network in Ontario, Canada, between October 2020 and May 2023. A ConvNeXt-Base architecture pretrained on ImageNet was trained to predict FEV₁/FVC, with predictions classified using a 0.70 cutoff for binary airflow limitation. At the patient level, the cohort was divided into training (n=2263), validation (n=566), and held-out test (n=708 patients; 3273 examinations) sets. Performance was assessed using regression (mean absolute error [MAE], root mean squared error [RMSE], and Pearson r), classification (sensitivity, specificity, positive and negative predictive value [PPV and NPV], and likelihood ratios [LR+ and LR-]), calibration, and decision curve metrics, with 95% CIs from patient-level cluster bootstrap (1000 resamples). Subgroup analyses used Holm correction and two 1-sided tests.

resultsIn the held-out test cohort, MAE was 0.08 (95% CI 0.07-0.09) and RMSE was 0.10 (95% CI 0.10-0.11). For binary obstruction, sensitivity was 0.70 (95% CI 0.65-0.74), specificity 0.72 (95% CI 0.67-0.76), PPV 0.71 (95% CI 0.65-0.76), NPV 0.71 (95% CI 0.66-0.76), LR+ 2.46 (95% CI 2.11-2.88), and LR- 0.42 (95% CI 0.36-0.49). Patient-level estimates were similar (sensitivity 0.69, 95% CI 0.66-0.72; specificity 0.74, 95% CI 0.71-0.78). Calibration was excellent for regression (slope=0.97; intercept=0.015) and mildly miscalibrated for the binary task (slope=1.41; intercept=0.04; Brier=0.195). Decision curve analysis showed net benefit at threshold probabilities of approximately 0.27 to 0.86. Sensitivity was meaningfully reduced in Asian patients (0.43, 95% CI 0.29-0.56) compared with White patients (0.75, 95% CI 0.70-0.79; absolute difference -0.32; Holm P<.001), with accompanying differences in specificity, PPV, and LR-, and was lower in younger age groups, peaking at 65-74 years.

conclusionsA deep learning model trained on routine chest radiographs estimated FEV₁/FVC and identified airflow limitation in a North American cohort, with moderate discrimination, well-calibrated regression predictions, and positive net benefit. Performance was not uniform across demographic strata, with reduced sensitivity in Asian patients and younger age groups. Multisite external validation and subgroup-specific verification are important next steps.

Indexed as

chest radiographydeep learningFEV1/FVC ratioforced expiratory volume in one second/forced vital capacity ratioobstructive lung diseasepulmonary function tests

Identifiers

PMID42555927
PMCPMC13490935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.